References
- Fuchs E. A Textbook of Ophthalmology. Philadelphia: JB Lippincott; 1908.
- Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234–235. doi:https://doi.org/10.1016/s0002-9394(14)74235-7.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:https://doi.org/10.1016/j.ajo.2005.03.057.
- Nussenblatt RB, Whitcup, SM, Palestine AG. Uveitis: fundamentals and clinical practice (pp. 350-71). Philadelphia: Mosby; 2004:350–71.
- Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103(2):131–136. doi:https://doi.org/10.1016/s0002-9394(14)74217-5.
- Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58(1):21–27. doi:https://doi.org/10.4103/0301-4738.58469.
- Lai WW, Pulido JS. Intermediate uveitis. Ophthalmol Clin N Am. 2002;15(3):309–317. doi:https://doi.org/10.1016/s0896-1549(02)00026-3.
- Vadot E. Epidemiology of intermediate uveitis: a prospective study in Savoy. Dev Ophthalmol. 1992;23:33–34. doi:https://doi.org/10.1159/000429625.
- Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:https://doi.org/10.1080/09273948.2016.1196713.
- Kimura SJ, Hogan MJ. Chronic cyclitis. Trans Am Ophthalmol Soc. 1963;61:397–417.
- Hogan MJ, Kimura SJ, O’Connor GR. Peripheral retinitis and chronic cyclitis in children. Trans Ophthalmol Soc UK. 1965;85:39–52.
- Jütte A, Lemke L, Opitz J. Chronic cyclitis in children. Ophthalmol J Int Ophtalmol Int J Ophthalmol Z Augenheilkd. 1969;157(3):169–177. doi:https://doi.org/10.1159/000305650.
- Althaus C, Sundmacher R. Intermediate uveitis: epidemiology, age and sex distribution. Dev Ophthalmol. 1992;23:9–14. doi:https://doi.org/10.1159/000429620.
- Biswas J, Raghavendran SR, Vijaya R. Intermediate uveitis of pars planitis type in identical twins. Report of a case. Int Ophthalmol. 1998;22(5):275–277. doi:https://doi.org/10.1023/a:1006327721918.
- Browning AC, Calladine D, Collins N, Harmer AW, Amoaku WM. HLA typing of a Hong Kong Chinese family with intermediate uveitis. Br J Ophthalmol. 2006;90(5):657. doi:https://doi.org/10.1136/bjo.2005.088658.
- Oruc S, Duffy BF, Mohanakumar T, Kaplan HJ. The association of HLA class II with pars planitis. Am J Ophthalmol. 2001;131(5):657–659. doi:https://doi.org/10.1016/s0002-9394(00)00863-1.
- Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. 1997;123(1):70–75. doi:https://doi.org/10.1016/s0002-9394(14)70994-8.
- Forooghian F, Cheung RK, Smith WC, O’Connor P, Dosch H-M. Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. J Clin Immunol. 2007;27(4):388–396. doi:https://doi.org/10.1007/s10875-007-9091-1.
- Schmidt S, Linington C, Zipp F, et al. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain J Neurol. 1997;120(Pt 8):1437–1445. doi:https://doi.org/10.1093/brain/120.8.1437.
- Casselman P, Cassiman C, Casteels I, Schauwvlieghe -P-P. Insights into multiple sclerosis-associated uveitis: a scoping review. Acta Ophthalmol (Copenh). Published online December 16, 2020 . doi:https://doi.org/10.1111/aos.14697.
- Opremcak EM, Cowans AB, Orosz CG, Adams PW, Whisler RL. Enumeration of autoreactive helper T lymphocytes in uveitis. Invest Ophthalmol Vis Sci. 1991;32:2561–2567.
- Davis JL, Chan CC, Nussenblatt RB. Immunology of intermediate uveitis. Dev Ophthalmol. 1992;23:71–85. doi:https://doi.org/10.1159/000429632.
- Boyd SR, Young S, Lightman S. Immunopathology of the noninfectious posterior and intermediate uveitides. Surv Ophthalmol. 2001;46(3):209–233. doi:https://doi.org/10.1016/s0039-6257(01)00275-2.
- Wetzig RP, Chan CC, Nussenblatt RB, Palestine AG, Mazur DO, Mittal KK. Clinical and immunopathological studies of pars planitis in a family. Br J Ophthalmol. 1988;72(1):5–10. doi:https://doi.org/10.1136/bjo.72.1.5.
- Nölle B, Eckardt C. Cellular phenotype of vitreous cells in intermediate uveitis. Dev Ophthalmol. 1992;23:145–149. doi:https://doi.org/10.1159/000429643.
- Green WR, Kincaid MC, Michels RG, Pederson JE, Kenyon KR, Maumenee AE. Pars planitis. Trans Ophthalmol Soc UK. 1981;101:361–367.
- Bora NS, Bora PS, Kaplan HJ. Identification, quantitation, and purification of a 36 kDa circulating protein associated with active pars planitis. Invest Ophthalmol Vis Sci. 1996;37:1870–1876.
- Ozdal PC, Berker N, Tugal-Tutkun I. Pars planitis: epidemiology, clinical characteristics, management and visual prognosis. J Ophthalmic Vis Res. 2015;10(4):469–480. doi:https://doi.org/10.4103/2008-322X.176897.
- Yoser SL, Forster DJ, Rao NA. Pathology of intermediate uveitis. Dev Ophthalmol. 1992;23:60–70. doi:https://doi.org/10.1159/000429631.
- Smith RE, Godfrey WA, Kimura SJ. Chronic cyclitis. I. Course and visual prognosis. Trans - Am Acad Ophthalmol Otolaryngol Am Acad Ophthalmol Otolaryngol. 1973;77: OP760-768.
- Lam S, Tessler HH. Intermediate uveitis. In: Tasman W, Jaeger EA, eds. Duane’s Clinical Ophthalmology. Vol. 4. Philadelphia: JB Lippincott; 1987:1–15.
- Welch RB, Maumenee AE, Wahlen HE. Peripheral posterior segment inflammation, vitreous opacities, and edema of the posterior pole. Arch Ophthalmol Chic IL 1960. 1960;64(4):540–549. doi:https://doi.org/10.1001/archopht.1960.01840010542010.
- Henderly DE, Haymond RS, Rao NA, Smith RE. The significance of the pars plana exudate in pars planitis. Am J Ophthalmol. 1987;103(5):669–671. doi:https://doi.org/10.1016/s0002-9394(14)74327-2.
- Capone A Jr., Aaberg TM. Intermediate uveitis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders; 1994:423–442.
- Chen PP, Chong LP. Coats’-like response in a patient with pars planitis. Br J Ophthalmol. 1996;80(7):675–676. doi:https://doi.org/10.1136/bjo.80.7.675.
- Suh DW, Pulido JS, Jampol LM, Chong LP, Thomas M. Coats’-like response in pars planitis. Retina Phila Pa. 1999;19(1):79–80. doi:https://doi.org/10.1097/00006982-199901000-00015.
- Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9(2):93–102. doi:https://doi.org/10.1076/ocii.9.2.93.3975.
- Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144(6):812–817. doi:https://doi.org/10.1016/j.ajo.2007.08.023.
- Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100(6):818–824; discussion 825. doi:https://doi.org/10.1016/s0161-6420(93)31567-8.
- Felder KS, Brockhurst RJ. Neovascular fundus abnormalities in peripheral uveitis. Arch Ophthalmol Chic IL 1960. 1982;100(5):750–754. doi:https://doi.org/10.1001/archopht.1982.01030030754006.
- Arkfeld DF, Brockhurst RJ. Peripapillary subretinal neovascularization in peripheral uveitis. Retina Phila Pa. 1985;5(3):157–160. doi:https://doi.org/10.1097/00006982-198500530-00005.
- Lauer AK, Smith JR, Robertson JE, Rosenbaum JT. Vitreous hemorrhage is a common complication of pediatric pars planitis. Ophthalmology. 2002;109(1):95–98. doi:https://doi.org/10.1016/s0161-6420(01)00866-1.
- Pruett RC, Brockhurst J, Letts NF. Fluorescein angiography of peripheral uveitis. Am J Ophthalmol. 1974;77(4):448–453. doi:https://doi.org/10.1016/0002-9394(74)90452-8.
- Brockhurst RJ, Schepens CL, Okamura ID. Uveitis. II. Peripheral uveitis: clinical description, complications and differential diagnosis. Am J Ophthalmol. 1960;49(6):1257–1266. doi:https://doi.org/10.1016/0002-9394(60)91340-4.
- Rousseau A, Terrada C, Touhami S, et al. Angiographic signatures of the predominant form of familial transthyretin amyloidosis (Val30Met mutation). Am J Ophthalmol. 2018;192:169–177. doi:https://doi.org/10.1016/j.ajo.2018.05.023.
- Schuman JS, Puliafito CA, Fujimoto JG. Optical Coherence Tomography of Ocular Diseases. 2nd ed. New Jersey: Slack Incorporated; 2004.
- Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol. 2004;49(5):470–490. doi:https://doi.org/10.1016/j.survophthal.2004.06.002.
- Takeda A, Ishibashi T, Sonoda K-H. Epidemiology of uveitis, caused by HTLV-1, toxoplasmosis, and tuberculosis; the three leading causes of endemic infectious uveitis in Japan. Ocul Immunol Inflamm. 2017;25(sup1):S19–S23. doi:https://doi.org/10.1080/09273948.2016.1253851.
- Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci. 2007;48(7):3253–3259. doi:https://doi.org/10.1167/iovs.06-0031.
- Pochat-Cotilloux C, Bienvenu J, Nguyen A-M, et al. Use of a threshold of Interleukin-10 and IL-10/IL-6 ratio in ocular samples for the screening of vitreoretinal lymphoma. Retina Phila Pa. 2018;38(4):773–781. doi:https://doi.org/10.1097/IAE.0000000000001922.
- Touhami S, Vanier A, Rosati A, et al. Predictive factors of intraocular pressure level evolution over time and glaucoma severity in fuchs’ heterochromic iridocyclitis. Invest Ophthalmol Vis Sci. 2019;60(7):2399–2405. doi:https://doi.org/10.1167/iovs.18-24597.
- Lei B, Zhou M, Wang Z, Chang Q, Xu G, Jiang R. Ultra-wide-field fundus imaging of acute retinal necrosis: clinical characteristics and visual significance. Eye Lond Engl. 2020;34(5):864–872. doi:https://doi.org/10.1038/s41433-019-0587-8.
- Bernard A, Seve P, Abukhashabh A, et al. Lyme-associated uveitis: clinical spectrum and review of literature. Eur J Ophthalmol. Published online June 26, 2019;30(5):1120672119856943. doi:https://doi.org/10.1177/1120672119856943.
- Bernard A, Kodjikian L, Abukhashabh A, et al. Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre. Br J Ophthalmol. 2018;102(3):369–372. doi:https://doi.org/10.1136/bjophthalmol-2017-310251.
- Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):14–24. doi:https://doi.org/10.3109/09273948.2014.986582.
- Kump L, Vitale AT, Foster CS. Pediatric uveitis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. New Delhi, India: Highlights Medical Publishers; 2013:1223 1225.
- Parchand S, Tandan M, Gupta V, Gupta A. Intermediate uveitis in Indian population. J Ophthalmic Inflamm Infect. 2011;1(2):65–70. doi:https://doi.org/10.1007/s12348-011-0020-3.
- Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:https://doi.org/10.1001/jamaophthalmol.2017.4485.
- Agrawal R, Betzler BK, Testi I, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 447 patients with tubercular intermediate uveitis and panuveitis. Ocul Immunol Inflamm. Published online November 17, 2020:1–11. doi:https://doi.org/10.1080/09273948.2020.1808226.
- Agrawal R, Testi I, Bodaghi B, et al. Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis. Ophthalmology. 2021;128(2):277–287. doi:https://doi.org/10.1016/j.ophtha.2020.06.052.
- Yıldız Balcı S, Turan Vural E, Özçalışkan Ş. Intermediate uveitis as the initial and only presentation of syphilis. Turk J Ophthalmol. 2019;49(5):297–299. doi:https://doi.org/10.4274/tjo.galenos.2019.72558.
- Ksiaa I, Abroug N, Mahmoud A, et al. Update on Bartonella neuroretinitis. J Curr Ophthalmol. 2019;31(3):254–261. doi:https://doi.org/10.1016/j.joco.2019.03.005.
- Kim M, Choi SY, Won JY, Park Y-H. Patterns of ocular toxoplasmosis presenting at a tertiary eye care center in Korean patients. Medicine (Baltimore). 2018;97(15):e0399. doi:https://doi.org/10.1097/MD.0000000000010399.
- Bourdin C, Busse A, Kouamou E, et al. PCR-based detection of Toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis. J Clin Microbiol. 2014;52(11):3987–3991. doi:https://doi.org/10.1128/JCM.01793-14.
- Okhravi N, Jones CD, Carroll N, Adamson P, Luthert P, Lightman S. Use of PCR to diagnose Toxoplasma gondii chorioretinitis in eyes with severe vitritis. Clin Exp Ophthalmol. 2005;33(2):184–187. doi:https://doi.org/10.1111/j.1442-9071.2005.00992.x.
- Despreaux R, Fardeau C, Touhami S, et al. Ocular toxocariasis: clinical features and long-term visual outcomes in adult patients. Am J Ophthalmol. 2016;166:162–168. doi:https://doi.org/10.1016/j.ajo.2016.03.050.
- Boskovich SA, Lowder CY, Meisler DM, Gutman FA. Systemic diseases associated with intermediate uveitis. Cleve Clin J Med. 1993;60(6):460–465. doi:https://doi.org/10.3949/ccjm.60.6.460.
- Touhami S, Audo I, Terrada C, et al. Neoplasia and intraocular inflammation: from masquerade syndromes to immunotherapy-induced uveitis. Prog Retin Eye Res. 2019;72:100761. doi:https://doi.org/10.1016/j.preteyeres.2019.05.002.
- Oliver GF, Carr JM, Smith JR. Emerging infectious uveitis: chikungunya, dengue, zika and ebola: a review. Clin Exp Ophthalmol. 2019;47(3):372–380. doi:https://doi.org/10.1111/ceo.13450.
- Thaler S, Grisanti S, Klingel K, Raible A, Kempf VA, Schulte B. Intermediate uveitis and arthralgia as early symptoms in Whipple’s disease. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2010;14(Suppl 3):e388–389. doi:https://doi.org/10.1016/j.ijid.2009.11.038.
- Avila MP, Jalkh AE, Feldman E, Trempe CL, Schepens CL. Manifestations of Whipple’s disease in the posterior segment of the eye. Arch Ophthalmol Chic IL 1960. 1984;102(3):384–390. doi:https://doi.org/10.1001/archopht.1984.01040030302024.
- Sivakumar R, Balakrishnan V, Gowri P, Visalakshi J. Leptospiral uveitis: usefulness of clinical signs as diagnostic predictors. Ocul Immunol Inflamm. 2018;26(4):569–576. doi:https://doi.org/10.1080/09273948.2016.1217341.
- Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc UK. 1976;96:151–157.
- Bregerbc BC, Leopold IH. The incidence of uveitis in multiple sclerosis. Am J Ophthalmol. 1966;62(3):540–545. doi:https://doi.org/10.1016/0002-9394(66)91340-7.
- Giles CL. Peripheral uveitis in patients with multiple sclerosis. Am J Ophthalmol. 1970;70(1):17–19. doi:https://doi.org/10.1016/0002-9394(70)90661-6.
- Gordon LK, Goldstein DA. Gender and uveitis in patients with multiple sclerosis. J Ophthalmol. 2014;2014:565262. doi:https://doi.org/10.1155/2014/565262.
- Lim JI, Tessler HH, Goodwin JA. Anterior granulomatous uveitis in patients with multiple sclerosis. Ophthalmology. 1991;98(2):142–145. doi:https://doi.org/10.1016/s0161-6420(91)32324-8.
- Towler HM, Lightman S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol. 2000;28(2):97–102. doi:https://doi.org/10.1046/j.1442-9071.2000.00270.x.
- Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis and other diseases in patients with pars planitis. Dev Ophthalmol. 1992;23:41–47. doi:https://doi.org/10.1159/000429628.
- Jain N, Bhatti MT. Fingolimod-associated macular edema: incidence, detection, and management. Neurology. 2012;78(9):672–680. doi:https://doi.org/10.1212/WNL.0b013e318248deea.
- Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12(2):137–142. doi:https://doi.org/10.1080/09273940490895344.
- Tugal-Tutkun I. Pediatric uveitis. J Ophthalmic Vis Res. 2011;6:259–269.
- Shetty AK, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J. 2008;6(1):16. doi:https://doi.org/10.1186/1546-0096-6-16.
- Manouvrier-Hanu S, Puech B, Piette F, et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet. 1998;76(3):217–221. doi:https://doi.org/10.1002/(SICI)1096-8628(19980319)76:3<217::AID-AJMG4>3.0.CO;2-N.
- Cunningham ET, Tugal-Tutkun I, Khairallah M, Okada AA, Bodaghi B, Zierhut M. Behçet Uveitis. Ocul Immunol Inflamm. 2017;25(1):2–6. doi:https://doi.org/10.1080/09273948.2017.1279840.
- International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol JEADV. 2014;28:(3):338–347. doi:https://doi.org/10.1111/jdv.12107.
- Whitcup SM. Intermediate uveitis. In: Nussenblatt RB, Whitcup SM, eds. Uveitis. Fundamentals and Clinical Practice. China: Elsevier; 2010:269 277.
- Cho B-J, Kim DY, Park UC, Lee JY, Yoon YH, Yu HG. Clinical features and treatment outcomes of vitreoretinal lymphoma according to its association with CNS lymphoma. Ocul Immunol Inflamm. 2018;26(3):365–371. doi:https://doi.org/10.1080/09273948.2017.1421669.
- Grimm SA, McCannel CA, Omuro AMP, et al. Primary CNS lymphoma with intraocular involvement: international PCNSL collaborative group report. Neurology. 2008;71(17):1355–1360. doi:https://doi.org/10.1212/01.wnl.0000327672.04729.8c.
- Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol Off J Eur Soc Med Oncol. 2007;18(11):1851–1855. doi:https://doi.org/10.1093/annonc/mdm340.
- Reichstein D. Primary vitreoretinal lymphoma: an update on pathogenesis, diagnosis and treatment. Curr Opin Ophthalmol. 2016;27(3):177–184. doi:https://doi.org/10.1097/ICU.0000000000000255.
- Touitou V, LeHoang P, Bodaghi B. Primary CNS lymphoma. Curr Opin Ophthalmol. 2015;26(6):526–533. doi:https://doi.org/10.1097/ICU.0000000000000213.
- Reynolds MM, Veverka KK, Gertz MA, et al. Ocular manifestations of systemic amyloidosis. Retina Phila Pa. 2018;38(7):1371–1376. doi:https://doi.org/10.1097/IAE.0000000000001901.
- Jager MJ, Shields CL, Cebulla CM, et al. Uveal melanoma. Nat Rev Dis Primer. 2020;6(1):24. doi:https://doi.org/10.1038/s41572-020-0158-0.
- Francis JH, Berry D, Abramson DH, et al. Intravitreous cutaneous metastatic melanoma in the era of checkpoint inhibition: unmasking and masquerading. Ophthalmology. 2020;127(2):240–248. doi:https://doi.org/10.1016/j.ophtha.2019.09.018.
- Kim CY, Ha CW, Lee SC. Vitreous and retinal metastasis from gastric cancer. Eur J Ophthalmol. 2010;20(3):615–617. doi:https://doi.org/10.1177/112067211002000316.
- Fukuda R, Tanabe T, Sawamura H, Kawata M, Tsuji H, Kaburaki T. Case of metastatic pulmonary carcinoma in optic disc diagnosed from results of biopsy performed during vitrectomy surgery. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2011;249(12):1883–1887. doi:https://doi.org/10.1007/s00417-011-1770-1.
- Mathis T, Jardel P, Loria O, et al. New concepts in the diagnosis and management of choroidal metastases. Prog Retin Eye Res. 2019;68:144–176. doi:https://doi.org/10.1016/j.preteyeres.2018.09.003.
- Shouchane-Blum K, Dotan A, Bahar I. The evolution of toxic anterior segment syndrome. Curr Opin Ophthalmol. 2019;30(1):50–55. doi:https://doi.org/10.1097/ICU.0000000000000540.
- Durand ML. Bacterial and Fungal Endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:https://doi.org/10.1128/CMR.00113-16.
- Sadiq MA, Hassan M, Agarwal A, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis. J Ophthalmic Inflamm Infect. 2015;5(1):32. doi:https://doi.org/10.1186/s12348-015-0063-y.
- Sun MM, Levinson RD, Filipowicz A, et al. Uveitis in patients treated with CTLA-4 and PD-1 checkpoint blockade inhibition. Ocul Immunol Inflamm. 2020;28(2):217–227. doi:https://doi.org/10.1080/09273948.2019.1577978.